These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24068010)

  • 1. Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations.
    Wormser GP; Levin A; Soman S; Adenikinju O; Longo MV; Branda JA
    J Clin Microbiol; 2013 Dec; 51(12):4045-9. PubMed ID: 24068010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
    Wormser GP; Schriefer M; Aguero-Rosenfeld ME; Levin A; Steere AC; Nadelman RB; Nowakowski J; Marques A; Johnson BJ; Dumler JS
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):9-15. PubMed ID: 23062467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
    Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
    Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.
    Branda JA; Strle F; Strle K; Sikand N; Ferraro MJ; Steere AC
    Clin Infect Dis; 2013 Aug; 57(3):333-40. PubMed ID: 23592827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
    Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease.
    Pratt GW; Platt M; Velez A; Rao LV
    J Appl Lab Med; 2022 Oct; 7(6):1445-1449. PubMed ID: 35716134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
    Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
    J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.
    Lipsett SC; Branda JA; Nigrovic LE
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
    Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
    J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.
    Engstrom SM; Shoop E; Johnson RC
    J Clin Microbiol; 1995 Feb; 33(2):419-27. PubMed ID: 7714202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
    Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
    Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting.
    Johnson BJ; Robbins KE; Bailey RE; Cao BL; Sviat SL; Craven RB; Mayer LW; Dennis DT
    J Infect Dis; 1996 Aug; 174(2):346-53. PubMed ID: 8699065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Novel Microarray Immunoblot Assay for Detection of IgM- and IgG-Class Antibodies to Borrelia burgdorferi.
    Theel ES; Sorenson M; Granger D
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
    Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
    Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
    Porwancher R; Landsberg L
    PLoS One; 2021; 16(9):e0253514. PubMed ID: 34499659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.